Oligonucleotides Industry Research Report 2024

Oligonucleotides Industry Research Report 2024


Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.

Highlights

The global Oligonucleotides market is projected to reach US$ million by 2030 from an estimated US$ million in 2024, at a CAGR of % during 2025 and 2030.
Global Oligonucleotides key players include Integrated DNA Technologies, Agilent, Sigma-aldrich, Eurofins Genomics, L.G.C Biosearch Technologies, etc. Global top five manufacturers hold a share over 45%.
North America is the largest market, with a share over 35%, followed by Europe and China, both have a share over 35percent.
In terms of product, DNA Oligos is the largest segment, with a share over 65%. And in terms of application, the largest application is Research, followed by Pharmaceutical.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oligonucleotides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oligonucleotides.
The Oligonucleotides market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oligonucleotides market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oligonucleotides companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Integrated DNA Technologies
Agilent
Sigma-aldrich
Eurofins Genomics
L.G.C Biosearch Technologies
Eurogentec S.A
Nitto Denko Avecia Inc
GenScript
BBI Life Sciences
GeneDesign
TriLink BioTechnologies
SGS DNA
LC Sciences
Twist Bioscience
Creative Biogene
General Biosystems

Product Type Insights

Global markets are presented by Oligonucleotides type, along with growth forecasts through 2030. Estimates on revenue are based on the price in the supply chain at which the Oligonucleotides are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2019-2024) and forecast period (2025-2030).
Oligonucleotides segment by Type

DNA Oligos
RNA Oligos

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2019-2024) and forecast period (2025-2030).
This report also outlines the market trends of each segment and consumer behaviors impacting the Oligonucleotides market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Oligonucleotides market.
Oligonucleotides Segment by Application
Pharmaceutical
Research
Diagnostic

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2019-2030.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2023 because of the base year, with estimates for 2024 and forecast revenue for 2030.

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Oligonucleotides market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oligonucleotides market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Oligonucleotides and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Oligonucleotides industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oligonucleotides.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Oligonucleotides companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Oligonucleotides by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
1.2.2 DNA Oligos
1.2.3 RNA Oligos
2.3 Oligonucleotides by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Pharmaceutical
2.3.3 Research
2.3.4 Diagnostic
2.4 Assumptions and Limitations
3 Oligonucleotides Breakdown Data by Type
3.1 Global Oligonucleotides Historic Market Size by Type (2019-2024)
3.2 Global Oligonucleotides Forecasted Market Size by Type (2025-2030)
4 Oligonucleotides Breakdown Data by Application
4.1 Global Oligonucleotides Historic Market Size by Application (2019-2024)
4.2 Global Oligonucleotides Forecasted Market Size by Application (2019-2024)
5 Global Growth Trends
5.1 Global Oligonucleotides Market Perspective (2019-2030)
5.2 Global Oligonucleotides Growth Trends by Region
5.2.1 Global Oligonucleotides Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Oligonucleotides Historic Market Size by Region (2019-2024)
5.2.3 Oligonucleotides Forecasted Market Size by Region (2025-2030)
5.3 Oligonucleotides Market Dynamics
5.3.1 Oligonucleotides Industry Trends
5.3.2 Oligonucleotides Market Drivers
5.3.3 Oligonucleotides Market Challenges
5.3.4 Oligonucleotides Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Oligonucleotides Players by Revenue
6.1.1 Global Top Oligonucleotides Players by Revenue (2019-2024)
6.1.2 Global Oligonucleotides Revenue Market Share by Players (2019-2024)
6.2 Global Oligonucleotides Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Oligonucleotides Head office and Area Served
6.4 Global Oligonucleotides Players, Product Type & Application
6.5 Global Oligonucleotides Players, Date of Enter into This Industry
6.6 Global Oligonucleotides Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Oligonucleotides Market Size (2019-2030)
7.2 North America Oligonucleotides Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Oligonucleotides Market Size by Country (2019-2024)
7.4 North America Oligonucleotides Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 Europe
8.1 Europe Oligonucleotides Market Size (2019-2030)
8.2 Europe Oligonucleotides Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Oligonucleotides Market Size by Country (2019-2024)
8.4 Europe Oligonucleotides Market Size by Country (2025-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Oligonucleotides Market Size (2019-2030)
9.2 Asia-Pacific Oligonucleotides Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Oligonucleotides Market Size by Country (2019-2024)
9.4 Asia-Pacific Oligonucleotides Market Size by Country (2025-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 Latin America
10.1 Latin America Oligonucleotides Market Size (2019-2030)
10.2 Latin America Oligonucleotides Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Oligonucleotides Market Size by Country (2019-2024)
10.4 Latin America Oligonucleotides Market Size by Country (2025-2030)
9.4 Mexico
9.5 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Oligonucleotides Market Size (2019-2030)
11.2 Middle East & Africa Oligonucleotides Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Oligonucleotides Market Size by Country (2019-2024)
11.4 Middle East & Africa Oligonucleotides Market Size by Country (2025-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 Players Profiled
11.1 Integrated DNA Technologies
11.1.1 Integrated DNA Technologies Company Detail
11.1.2 Integrated DNA Technologies Business Overview
11.1.3 Integrated DNA Technologies Oligonucleotides Introduction
11.1.4 Integrated DNA Technologies Revenue in Oligonucleotides Business (2017-2022)
11.1.5 Integrated DNA Technologies Recent Development
11.2 Agilent
11.2.1 Agilent Company Detail
11.2.2 Agilent Business Overview
11.2.3 Agilent Oligonucleotides Introduction
11.2.4 Agilent Revenue in Oligonucleotides Business (2017-2022)
11.2.5 Agilent Recent Development
11.3 Sigma-aldrich
11.3.1 Sigma-aldrich Company Detail
11.3.2 Sigma-aldrich Business Overview
11.3.3 Sigma-aldrich Oligonucleotides Introduction
11.3.4 Sigma-aldrich Revenue in Oligonucleotides Business (2017-2022)
11.3.5 Sigma-aldrich Recent Development
11.4 Eurofins Genomics
11.4.1 Eurofins Genomics Company Detail
11.4.2 Eurofins Genomics Business Overview
11.4.3 Eurofins Genomics Oligonucleotides Introduction
11.4.4 Eurofins Genomics Revenue in Oligonucleotides Business (2017-2022)
11.4.5 Eurofins Genomics Recent Development
11.5 L.G.C Biosearch Technologies
11.5.1 L.G.C Biosearch Technologies Company Detail
11.5.2 L.G.C Biosearch Technologies Business Overview
11.5.3 L.G.C Biosearch Technologies Oligonucleotides Introduction
11.5.4 L.G.C Biosearch Technologies Revenue in Oligonucleotides Business (2017-2022)
11.5.5 L.G.C Biosearch Technologies Recent Development
11.6 Eurogentec S.A
11.6.1 Eurogentec S.A Company Detail
11.6.2 Eurogentec S.A Business Overview
11.6.3 Eurogentec S.A Oligonucleotides Introduction
11.6.4 Eurogentec S.A Revenue in Oligonucleotides Business (2017-2022)
11.6.5 Eurogentec S.A Recent Development
11.7 Nitto Denko Avecia Inc
11.7.1 Nitto Denko Avecia Inc Company Detail
11.7.2 Nitto Denko Avecia Inc Business Overview
11.7.3 Nitto Denko Avecia Inc Oligonucleotides Introduction
11.7.4 Nitto Denko Avecia Inc Revenue in Oligonucleotides Business (2017-2022)
11.7.5 Nitto Denko Avecia Inc Recent Development
11.8 GenScript
11.8.1 GenScript Company Detail
11.8.2 GenScript Business Overview
11.8.3 GenScript Oligonucleotides Introduction
11.8.4 GenScript Revenue in Oligonucleotides Business (2017-2022)
11.8.5 GenScript Recent Development
11.9 BBI Life Sciences
11.9.1 BBI Life Sciences Company Detail
11.9.2 BBI Life Sciences Business Overview
11.9.3 BBI Life Sciences Oligonucleotides Introduction
11.9.4 BBI Life Sciences Revenue in Oligonucleotides Business (2017-2022)
11.9.5 BBI Life Sciences Recent Development
11.10 GeneDesign
11.10.1 GeneDesign Company Detail
11.10.2 GeneDesign Business Overview
11.10.3 GeneDesign Oligonucleotides Introduction
11.10.4 GeneDesign Revenue in Oligonucleotides Business (2017-2022)
11.10.5 GeneDesign Recent Development
11.11 TriLink BioTechnologies
11.11.1 TriLink BioTechnologies Company Detail
11.11.2 TriLink BioTechnologies Business Overview
11.11.3 TriLink BioTechnologies Oligonucleotides Introduction
11.11.4 TriLink BioTechnologies Revenue in Oligonucleotides Business (2017-2022)
11.11.5 TriLink BioTechnologies Recent Development
11.12 SGS DNA
11.12.1 SGS DNA Company Detail
11.12.2 SGS DNA Business Overview
11.12.3 SGS DNA Oligonucleotides Introduction
11.12.4 SGS DNA Revenue in Oligonucleotides Business (2017-2022)
11.12.5 SGS DNA Recent Development
11.13 LC Sciences
11.13.1 LC Sciences Company Detail
11.13.2 LC Sciences Business Overview
11.13.3 LC Sciences Oligonucleotides Introduction
11.13.4 LC Sciences Revenue in Oligonucleotides Business (2017-2022)
11.13.5 LC Sciences Recent Development
11.14 Twist Bioscience
11.14.1 Twist Bioscience Company Detail
11.14.2 Twist Bioscience Business Overview
11.14.3 Twist Bioscience Oligonucleotides Introduction
11.14.4 Twist Bioscience Revenue in Oligonucleotides Business (2017-2022)
11.14.5 Twist Bioscience Recent Development
11.15 Creative Biogene
11.15.1 Creative Biogene Company Detail
11.15.2 Creative Biogene Business Overview
11.15.3 Creative Biogene Oligonucleotides Introduction
11.15.4 Creative Biogene Revenue in Oligonucleotides Business (2017-2022)
11.15.5 Creative Biogene Recent Development
11.16 General Biosystems
11.16.1 General Biosystems Company Detail
11.16.2 General Biosystems Business Overview
11.16.3 General Biosystems Oligonucleotides Introduction
11.16.4 General Biosystems Revenue in Oligonucleotides Business (2017-2022)
11.16.5 General Biosystems Recent Development
13 Report Conclusion
14 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 4. Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 5. Global Oligonucleotides Market Size by Type (2019-2024) & (US$ Million)
Table 6. Global Oligonucleotides Revenue Market Share by Type (2019-2024)
Table 7. Global Oligonucleotides Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 8. Global Oligonucleotides Revenue Market Share by Type (2025-2030)
Table 9. Global Oligonucleotides Market Size by Application (2019-2024) & (US$ Million)
Table 10. Global Oligonucleotides Revenue Market Share by Application (2019-2024)
Table 11. Global Oligonucleotides Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 12. Global Oligonucleotides Revenue Market Share by Application (2025-2030)
Table 13. Global Oligonucleotides Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 14. Global Oligonucleotides Market Size by Region (2019-2024) & (US$ Million)
Table 15. Global Oligonucleotides Market Share by Region (2019-2024)
Table 16. Global Oligonucleotides Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 17. Global Oligonucleotides Market Share by Region (2025-2030)
Table 18. Oligonucleotides Market Trends
Table 19. Oligonucleotides Market Drivers
Table 20. Oligonucleotides Market Challenges
Table 21. Oligonucleotides Market Restraints
Table 22. Global Top Oligonucleotides Manufacturers by Revenue (US$ Million) & (2019-2024)
Table 23. Global Oligonucleotides Revenue Market Share by Manufacturers (2019-2024)
Table 24. Global Oligonucleotides Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 25. Global Key Players of Oligonucleotides, Headquarters and Area Served
Table 26. Global Oligonucleotides Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Oligonucleotides by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Oligonucleotides Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. North America Oligonucleotides Market Size by Country (2019-2024) & (US$ Million)
Table 32. North America Oligonucleotides Market Size by Country (2025-2030) & (US$ Million)
Table 33. Europe Oligonucleotides Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 34. Europe Oligonucleotides Market Size by Country (2019-2024) & (US$ Million)
Table 35. Europe Oligonucleotides Market Size by Country (2025-2030) & (US$ Million)
Table 36. Asia-Pacific Oligonucleotides Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 37. Asia-Pacific Oligonucleotides Market Size by Country (2019-2024) & (US$ Million)
Table 38. Asia-Pacific Oligonucleotides Market Size by Country (2025-2030) & (US$ Million)
Table 39. Latin America Oligonucleotides Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 40. Latin America Oligonucleotides Market Size by Country (2019-2024) & (US$ Million)
Table 41. Latin America Oligonucleotides Market Size by Country (2025-2030) & (US$ Million)
Table 42. Middle East & Africa Oligonucleotides Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 43. Middle East & Africa Oligonucleotides Market Size by Country (2019-2024) & (US$ Million)
Table 44. Middle East & Africa Oligonucleotides Market Size by Country (2025-2030) & (US$ Million)
Table 45. Integrated DNA Technologies Company Detail
Table 46. Integrated DNA Technologies Business Overview
Table 47. Integrated DNA Technologies Oligonucleotides Product
Table 48. Integrated DNA Technologies Revenue in Oligonucleotides Business (2017-2022) & (US$ Million)
Table 49. Integrated DNA Technologies Recent Development
Table 50. Agilent Company Detail
Table 51. Agilent Business Overview
Table 52. Agilent Oligonucleotides Product
Table 53. Agilent Revenue in Oligonucleotides Business (2017-2022) & (US$ Million)
Table 54. Agilent Recent Development
Table 55. Sigma-aldrich Company Detail
Table 56. Sigma-aldrich Business Overview
Table 57. Sigma-aldrich Oligonucleotides Product
Table 58. Sigma-aldrich Revenue in Oligonucleotides Business (2017-2022) & (US$ Million)
Table 59. Sigma-aldrich Recent Development
Table 60. Eurofins Genomics Company Detail
Table 61. Eurofins Genomics Business Overview
Table 62. Eurofins Genomics Oligonucleotides Product
Table 63. Eurofins Genomics Revenue in Oligonucleotides Business (2017-2022) & (US$ Million)
Table 64. Eurofins Genomics Recent Development
Table 65. L.G.C Biosearch Technologies Company Detail
Table 66. L.G.C Biosearch Technologies Business Overview
Table 67. L.G.C Biosearch Technologies Oligonucleotides Product
Table 68. L.G.C Biosearch Technologies Revenue in Oligonucleotides Business (2017-2022) & (US$ Million)
Table 69. L.G.C Biosearch Technologies Recent Development
Table 70. Eurogentec S.A Company Detail
Table 71. Eurogentec S.A Business Overview
Table 72. Eurogentec S.A Oligonucleotides Product
Table 73. Eurogentec S.A Revenue in Oligonucleotides Business (2017-2022) & (US$ Million)
Table 74. Eurogentec S.A Recent Development
Table 75. Nitto Denko Avecia Inc Company Detail
Table 76. Nitto Denko Avecia Inc Business Overview
Table 77. Nitto Denko Avecia Inc Oligonucleotides Product
Table 78. Nitto Denko Avecia Inc Revenue in Oligonucleotides Business (2017-2022) & (US$ Million)
Table 79. Nitto Denko Avecia Inc Recent Development
Table 80. GenScript Company Detail
Table 81. GenScript Business Overview
Table 82. GenScript Oligonucleotides Product
Table 83. GenScript Revenue in Oligonucleotides Business (2017-2022) & (US$ Million)
Table 84. GenScript Recent Development
Table 85. BBI Life Sciences Company Detail
Table 86. BBI Life Sciences Business Overview
Table 87. BBI Life Sciences Oligonucleotides Product
Table 88. BBI Life Sciences Revenue in Oligonucleotides Business (2017-2022) & (US$ Million)
Table 89. BBI Life Sciences Recent Development
Table 90. GeneDesign Company Detail
Table 91. GeneDesign Business Overview
Table 92. GeneDesign Oligonucleotides Product
Table 93. GeneDesign Revenue in Oligonucleotides Business (2017-2022) & (US$ Million)
Table 94. GeneDesign Recent Development
Table 95. TriLink BioTechnologies Company Detail
Table 96. TriLink BioTechnologies Business Overview
Table 97. TriLink BioTechnologies OligonucleotidesProduct
Table 98. TriLink BioTechnologies Revenue in Oligonucleotides Business (2017-2022) & (US$ Million)
Table 99. TriLink BioTechnologies Recent Development
Table 100. SGS DNA Company Detail
Table 101. SGS DNA Business Overview
Table 102. SGS DNA OligonucleotidesProduct
Table 103. SGS DNA Revenue in Oligonucleotides Business (2017-2022) & (US$ Million)
Table 104. SGS DNA Recent Development
Table 105. LC Sciences Company Detail
Table 106. LC Sciences Business Overview
Table 107. LC Sciences OligonucleotidesProduct
Table 108. LC Sciences Revenue in Oligonucleotides Business (2017-2022) & (US$ Million)
Table 109. LC Sciences Recent Development
Table 110. Twist Bioscience Company Detail
Table 111. Twist Bioscience Business Overview
Table 112. Twist Bioscience OligonucleotidesProduct
Table 113. Twist Bioscience Revenue in Oligonucleotides Business (2017-2022) & (US$ Million)
Table 114. Twist Bioscience Recent Development
Table 115. Creative Biogene Company Detail
Table 116. Creative Biogene Business Overview
Table 117. Creative Biogene OligonucleotidesProduct
Table 118. Creative Biogene Revenue in Oligonucleotides Business (2017-2022) & (US$ Million)
Table 119. Creative Biogene Recent Development
Table 120. General Biosystems Company Detail
Table 121. General Biosystems Business Overview
Table 122. General Biosystems OligonucleotidesProduct
Table 123. General Biosystems Revenue in Oligonucleotides Business (2017-2022) & (US$ Million)
Table 124. General Biosystems Recent Development
Table 125. Integrated DNA Technologies Company Information
Table 126. Integrated DNA Technologies Business Overview
Table 127. Integrated DNA Technologies Oligonucleotides Revenue in Oligonucleotides Business (2019-2024) & (US$ Million)
Table 128. Integrated DNA Technologies Revenue in Oligonucleotides Business (2019-2024) & (US$ Million) Portfolio
Table 129. Integrated DNA Technologies Recent Development
Table 130. Agilent Company Information
Table 131. Agilent Business Overview
Table 132. Agilent Oligonucleotides Revenue in Oligonucleotides Business (2019-2024) & (US$ Million)
Table 133. Agilent Revenue in Oligonucleotides Business (2019-2024) & (US$ Million) Portfolio
Table 134. Agilent Recent Development
Table 135. Sigma-aldrich Company Information
Table 136. Sigma-aldrich Business Overview
Table 137. Sigma-aldrich Oligonucleotides Revenue in Oligonucleotides Business (2019-2024) & (US$ Million)
Table 138. Sigma-aldrich Revenue in Oligonucleotides Business (2019-2024) & (US$ Million) Portfolio
Table 139. Sigma-aldrich Recent Development
Table 140. Eurofins Genomics Company Information
Table 141. Eurofins Genomics Business Overview
Table 142. Eurofins Genomics Oligonucleotides Revenue in Oligonucleotides Business (2019-2024) & (US$ Million)
Table 143. Eurofins Genomics Revenue in Oligonucleotides Business (2019-2024) & (US$ Million) Portfolio
Table 144. Eurofins Genomics Recent Development
Table 145. L.G.C Biosearch Technologies Company Information
Table 146. L.G.C Biosearch Technologies Business Overview
Table 147. L.G.C Biosearch Technologies Oligonucleotides Revenue in Oligonucleotides Business (2019-2024) & (US$ Million)
Table 148. L.G.C Biosearch Technologies Revenue in Oligonucleotides Business (2019-2024) & (US$ Million) Portfolio
Table 149. L.G.C Biosearch Technologies Recent Development
Table 150. Eurogentec S.A Company Information
Table 151. Eurogentec S.A Business Overview
Table 152. Eurogentec S.A Oligonucleotides Revenue in Oligonucleotides Business (2019-2024) & (US$ Million)
Table 153. Eurogentec S.A Revenue in Oligonucleotides Business (2019-2024) & (US$ Million) Portfolio
Table 154. Eurogentec S.A Recent Development
Table 155. Nitto Denko Avecia Inc Company Information
Table 156. Nitto Denko Avecia Inc Business Overview
Table 157. Nitto Denko Avecia Inc Oligonucleotides Revenue in Oligonucleotides Business (2019-2024) & (US$ Million)
Table 158. Nitto Denko Avecia Inc Revenue in Oligonucleotides Business (2019-2024) & (US$ Million) Portfolio
Table 159. Nitto Denko Avecia Inc Recent Development
Table 160. GenScript Company Information
Table 161. GenScript Business Overview
Table 162. GenScript Oligonucleotides Revenue in Oligonucleotides Business (2019-2024) & (US$ Million)
Table 163. GenScript Revenue in Oligonucleotides Business (2019-2024) & (US$ Million) Portfolio
Table 164. GenScript Recent Development
Table 165. BBI Life Sciences Company Information
Table 166. BBI Life Sciences Business Overview
Table 167. BBI Life Sciences Oligonucleotides Revenue in Oligonucleotides Business (2019-2024) & (US$ Million)
Table 168. BBI Life Sciences Revenue in Oligonucleotides Business (2019-2024) & (US$ Million) Portfolio
Table 169. BBI Life Sciences Recent Development
Table 170. GeneDesign Company Information
Table 171. GeneDesign Business Overview
Table 172. GeneDesign Oligonucleotides Revenue in Oligonucleotides Business (2019-2024) & (US$ Million)
Table 173. GeneDesign Revenue in Oligonucleotides Business (2019-2024) & (US$ Million) Portfolio
Table 174. GeneDesign Recent Development
Table 175. TriLink BioTechnologies Company Information
Table 176. TriLink BioTechnologies Business Overview
Table 177. TriLink BioTechnologies OligonucleotidesRevenue in Oligonucleotides Business (2019-2024) & (US$ Million)
Table 178. TriLink BioTechnologies Revenue in Oligonucleotides Business (2019-2024) & (US$ Million) Portfolio
Table 179. TriLink BioTechnologies Recent Development
Table 180. SGS DNA Company Information
Table 181. SGS DNA Business Overview
Table 182. SGS DNA OligonucleotidesRevenue in Oligonucleotides Business (2019-2024) & (US$ Million)
Table 183. SGS DNA Revenue in Oligonucleotides Business (2019-2024) & (US$ Million) Portfolio
Table 184. SGS DNA Recent Development
Table 185. LC Sciences Company Information
Table 186. LC Sciences Business Overview
Table 187. LC Sciences OligonucleotidesRevenue in Oligonucleotides Business (2019-2024) & (US$ Million)
Table 188. LC Sciences Revenue in Oligonucleotides Business (2019-2024) & (US$ Million) Portfolio
Table 189. LC Sciences Recent Development
Table 190. Twist Bioscience Company Information
Table 191. Twist Bioscience Business Overview
Table 192. Twist Bioscience OligonucleotidesRevenue in Oligonucleotides Business (2019-2024) & (US$ Million)
Table 193. Twist Bioscience Revenue in Oligonucleotides Business (2019-2024) & (US$ Million) Portfolio
Table 194. Twist Bioscience Recent Development
Table 195. Creative Biogene Company Information
Table 196. Creative Biogene Business Overview
Table 197. Creative Biogene OligonucleotidesRevenue in Oligonucleotides Business (2019-2024) & (US$ Million)
Table 198. Creative Biogene Revenue in Oligonucleotides Business (2019-2024) & (US$ Million) Portfolio
Table 199. Creative Biogene Recent Development
Table 200. General Biosystems Company Information
Table 201. General Biosystems Business Overview
Table 202. General Biosystems OligonucleotidesRevenue in Oligonucleotides Business (2019-2024) & (US$ Million)
Table 203. General Biosystems Revenue in Oligonucleotides Business (2019-2024) & (US$ Million) Portfolio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings